Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells

Janet Glassford1, Neil Rabin, Eric W-F Lam

  • 1Department of Haematology, University College London, London, UK. j.glassford@ucl.ac.uk

Insights

D-type cyclins are functionally regulated in multiple myeloma (MM), with expression linked to disease progression. Their activity, influenced by specific genetic translocations, drives cell cycle progression in MM patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • D-type cyclin genes are dysregulated in multiple myeloma (MM), but their functional impact on proliferation and disease progression remains unclear.
  • Previous studies show gene expression doesn't correlate with MM progression, necessitating protein-level investigation.

Purpose of the Study:

  • To investigate the protein expression and functional regulation of D-type cyclins and cell cycle regulators in MM.
  • To determine how IgH translocations influence D-type cyclin function and response to microenvironmental stimuli.

Main Methods:

  • Analysis of protein expression of D-type cyclins (D1, D2), CDKs (4, 6), p27(Kip1), p18(INK4C), and pRb in human MM cell lines and primary CD138(+) plasma cells (PCs).
  • Assessing the functional consequences of cyclin D2 and D1 expression, particularly in relation to IgH translocations (t(14;16), t(4;14), t(11;14)) and exogenous stimuli (fetal calf serum, IGF-I).

Main Results:

  • Cyclins D1, D2, CDK4, CDK6, p27(Kip1), p18(INK4C), and pRb were absent in normal PCs but heterogeneously expressed in MM cells, correlating with disease activity.
  • Cyclins D1 and D2 formed complexes with CDK4/CDK6, leading to pRb phosphorylation and cell cycle progression.
  • Cyclin D2, upregulated by translocations and growth factors, drove cell cycle progression, sometimes inversely with p27(Kip1); cyclin D1-mediated progression was less stimulus-dependent.

Conclusions:

  • D-type cyclins are functionally regulated in MM, with aberrant expression linked to disease progression.
  • The specific IgH translocations influence the responsiveness of D-type cyclins to microenvironmental growth factors.
  • This study provides the first evidence of functional regulation and differential responsiveness of D-type cyclins in MM.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...